UVB irradiation decreases the magnitude of the Th1 response to hapten but does not increase the Th2 response.
Exposure of murine skin to low doses of ultraviolet-B (UVB) radiation before sensitization with hapten reduces the ability of antigen presenting cells (APC) in the draining lymph nodes to initiate contact hypersensitivity responses in vivo and results in the induction of hapten-specific suppressor T cells. In the present study, we tested the hypothesis that exposure of skin to UVB radiation suppresses T cell responses to hapten in vivo by altering the functions of APC, resulting in decreased stimulation of Th1 lymphocytes, which mediate contact hypersensitivity responses, and preferential activation of Th2 cells. C3H/HeN mice were exposed to either a single 2 kJ/m2 dose of UVB or to 400 J/m2 of UVB daily from FS40 sunlamps for four consecutive days and sensitized with fluorescein isothiocyanate on UV-irradiated skin. Draining lymph node cells were collected 18 h after sensitization and co-cultured with nylon wool-purified T cells from naive or fluorescein-immunized mice. Unseparated lymph node cells or sorter-purified fluorescein-bearing APC from UV-irradiated mice induced less T cell proliferation than APC from non-UV-exposed mice. Lymph node cells produced less Th1 and Th2-associated cytokines, interferon-gamma and interleukin-4, respectively, in response to APC from UV-irradiated animals compared with APC from unirradiated, fluorescein-sensitized mice. Thus, low doses of UV radiation do not result in preferential stimulation of Th2 response in lymph nodes, and results from cloned cell lines may incompletely reflect T cell responses in vivo.
Saijo
S
S
Department of Immunology, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA.
Kodari
E
E
Kripke
M L
ML
Strickland
F M
FM
D000818:Animals; D000938:Antigen-Presenting Cells / Q000528:radiation effects; D002455:Cell Division; D016207:Cytokines / Q000276:immunology; D003877:Dermatitis, Contact / Q000276:immunology / Q000473:pathology; D005260:Female; D016650:Fluorescein-5-isothiocyanate / Q000008:administration & dosage / Q000009:adverse effects*; D006241:Haptens / Q000008:administration & dosage / Q000009:adverse effects*; D007114:Immunization; D007371:Interferon-gamma / Q000276:immunology; D015847:Interleukin-4 / Q000276:immunology; D008198:Lymph Nodes / Q000473:pathology; D008213:Lymphocyte Activation / Q000276:immunology; D051379:Mice; D008809:Mice, Inbred C3H; D008815:Mice, Inbred Strains; D011829:Radiation Dosage; D012867:Skin / Q000528:radiation effects*; D050378:T-Lymphocytes, Regulatory / Q000276:immunology; D018417:Th1 Cells / Q000276:immunology / Q000528:radiation effects*; D018418:Th2 Cells / Q000276:immunology / Q000528:radiation effects*; D014466:Ultraviolet Rays / Q000145:classification
D016207:Cytokines; D006241:Haptens; D015847:Interleukin-4; D007371:Interferon-gamma; D016650:Fluorescein-5-isothiocyanate